Tuesday 31st January 2017
|Text too small?|
Better Health Co has sold an 80 percent stake to an Asian private equity fund to help the Lower Hutt-based supplements maker break into export markets.
The Overseas Investment Office approved the deal in December, where ORA New Zealand, a private equity fund ultimately controlled by pan-Asian alternative asset fund manager China Diamond Holdings, acquired the stake in "sensitive land" and "significant business assets". The consideration paid was withheld.
The Better Health Co manufactures and distributes natural health products under the GO Healthy brand, sold exclusively through pharmacies and health stores.
The OIO summary decision, released today, says the vendors had "achieved a number of its initial strategic objectives and is the market leader in its New Zealand distribution channel" and wanted to use that brand to enter international markets.
"The vendors wished to include in the business a strategic partner who could assist with speed of entry into international markets. A partner was sought that has the resources, capability and willingness to accelerate the growth of GO Healthy," the notice said. "The applicant intends to act as a catalyst for expansion of the Go Healthy business and unlock value for all stakeholders by providing the needed assistance and resources to the existing management team in its efforts to capture these new opportunities."
The deal is the latest where Asian investors have shown an interest in Australasian food supplements businesses, with Vitaco Health Group taken over by a Chinese-led consortium last year after a brief period on the ASX.
No comments yet
MARKET CLOSE: NZ shares fall as raft of earnings loom; Heartland, Fletcher drop, Sky TV, Air NZ gain
NZ dollar falls vs greenback, Aussie as investors seek clues over diverging rate tracks
NZ's housing-related imbalances set to peak in 2018, S&P Global says
Bapcor's ex-Hellaby auto unit still exceeding expectations
KiwiRail operating earnings rise despite Kaikoura line outage
Used car import body says 'short-term' hit from MPI's stink bug strategy worth it
CBL's European subsidiary fights Irish central bank ban on new business
ASX-listed Super Retail Group pays $144M for Macpac, more than twice the 2015 price
Mark Tume appointed chair of Ngāi Tahu Holdings board
ANZ extends Veritas' debt for a third time, seeking shareholder approval to sell Mad Butcher